Xiangqin He

1.7k total citations · 1 hit paper
40 papers, 1.1k citations indexed

About

Xiangqin He is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiangqin He has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiangqin He's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (5 papers). Xiangqin He is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (5 papers). Xiangqin He collaborates with scholars based in China, United States and South Korea. Xiangqin He's co-authors include Yanyan Yang, Tao Yu, Meixin Liu, Xiuxiu Fu, Tianxiang Li, Peifeng Li, Weigang Cui, Hongzhao Qi, Lin Zhang and Ruicong Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Xiangqin He

36 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR/Cas9 therapeutics: progress and prospects

2023 388 citations Tianxiang Li, Yanyan Yang et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Xiangqin He

Since Specialization

Citations

This map shows the geographic impact of Xiangqin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqin He more than expected).

Fields of papers citing papers by Xiangqin He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangqin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqin He. The network helps show where Xiangqin He may publish in the future.

Co-authorship network of co-authors of Xiangqin He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqin He. A scholar is included among the top collaborators of Xiangqin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqin He. Xiangqin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of circular EYA3 attenuates formaldehyde-induced cardiomyocyte pyroptosis and congenital heart defects by regulating Smad5 stability 2025 ·The Science of The Total Environment ·Ying Zhang, Yanyan Yang, Xiangqin He, Pin Sun, Xiaoxia Song, Yu Tian, (unknown), Ruicong Sun, Tao Yu, Zhirong Jiang	0
2	Protein palmitoylation: A potential therapeutic target in cardiovascular diseases 2025 ·Acta Pharmaceutica Sinica B ·(unknown), Yanyan Yang, Hong Li, Pin Sun, Xiangqin He, Chao Wang, Jingjing Zhang, Yu Tian, Tao Yu, Zhirong Jiang	0
3	LncRNA 91234.1 targets PRMT1/ASCL4/GPX4 axis to regulate formaldehyde-induced cardiomyocyte ferroptosis and congenital heart disease 2025 ·Journal of Molecular and Cellular Cardiology ·(unknown), Pin Sun, Chao Wang, Xiaolu Li, Zhilong Xiu, Yu Tian, Xiaoxia Song, Xiangqin He, Tao Yu, Zhirong Jiang	2
4	A novel mouse model carrying a gene trap insertion into the Hmgxb4 gene locus to examine Hmgxb4 expression in vivo 2024 ·Physiological Reports ·Liang Wang, Xiangqin He, Guoqing Hu, Jinhua Liu, Xiuhua Kang, (unknown), Kunzhe Dong, (unknown), Aizhen Zhang, Wei Zhang, Michael W. Brands, Huabo Su, Zeqi Zheng, Jiliang Zhou	1
5	CircTMEM165 facilitates endothelial repair by modulating mitochondrial fission via miR-192/SCP2 in vitro and in vivo 2024 ·iScience ·Yan Liu, Yanyan Yang, Min Li, Xiuxiu Fu, Xiangqin He, Xiaoxin Li, Jae Youl Cho, Peifeng Li, Tao Yu	8
6	Roles of long non-coding RNAs in angiogenesis-related diseases: Focusing on non-neoplastic aspects 2023 ·Life Sciences ·(unknown), (unknown), Xiangqin He, Ni Wang, Ruicong Sun, Xiaolu Li, Tao Yu, Xian‐Ming Chu	6
7	The Long Noncoding RNA Cardiac Mesoderm Enhancer-Associated Noncoding RNA (Carmn) Is a Critical Regulator of Gastrointestinal Smooth Muscle Contractile Function and Motility 2023 ·Gastroenterology ·Xiangqin He, (unknown), Jian Shen, Guoqing Hu, James Mintz, Reem T. Atawia, (unknown), Xiuxu Chen, Robert W. Caldwell, Meixiang Xiang, David W. Stepp, David Fulton, Jiliang Zhou	10
8	CRISPR/Cas9 therapeutics: progress and prospects breakdown → 2023 ·Signal Transduction and Targeted Therapy ·Tianxiang Li, Yanyan Yang, Hongzhao Qi, Weigang Cui, Lin Zhang, Xiuxiu Fu, Xiangqin He, Meixin Liu, Peifeng Li, Tao Yu	388
9	miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection 2022 ·Journal of Molecular and Cellular Cardiology ·Min Li, Yanyan Yang, Jinbao Zong, Zhibin Wang, Shaoyan Jiang, Xiuxiu Fu, Xiangqin He, Xiaoxin Li, Qianqian Xue, Jianxun Wang, Tao Yu	24
10	Comprehensive profile of circRNAs in formaldehyde induced heart development 2022 ·Food and Chemical Toxicology ·Ying Zhang, Yanyan Yang, Hui Ju, Xiangqin He, Pin Sun, Yu Tian, Panyu Yang, Xiaoxia Song, Tao Yu, Zhirong Jiang	14
11	Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA via Inhibiting Inflammation 2022 ·Journal of Inflammation Research ·Chao Tian, Yanyan Yang, Bing Li, Meixin Liu, Xiangqin He, Liang Zhao, Xiaoxia Song, Tao Yu, Xian‐Ming Chu	9
12	Lysine Malonylation and Its Links to Metabolism and Diseases 2022 ·Aging and Disease ·Lu Zou, Yanyan Yang, Zhibin Wang, Xiuxiu Fu, Xiangqin He, Jiayi Song, Tianxiang Li, (unknown), Tao Yu	37
13	The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease 2021 ·Molecular Therapy — Nucleic Acids ·(unknown), Yanyan Yang, Xiuxiu Fu, Xiangqin He, Meixin Liu, Tingyu Zong, Xiaolu Li, Lynn Htet Htet Aung, (unknown), Tao Yu	31
14	YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation 2021 ·Journal of Molecular and Cellular Cardiology ·Islam Osman, Kunzhe Dong, Xiuhua Kang, (unknown), Fei Xu, Abu Ahmed, Xiangqin He, Jian Shen, Guoqing Hu, Wei Zhang, Jiliang Zhou	23
15	Left Atrial Strain and Compliance Correlate with Diastolic Dysfunction Grades and Complications during Pre-eclampsia: A Speckle-Tracking Echocardiography Study 2021 ·Ultrasound in Medicine & Biology ·Rui Li, Fei Sun, (unknown), Xiangqin He, Rong Li, Lin Xu, Guanghui Song, (unknown)	5
16	Role of acetylation in doxorubicin-induced cardiotoxicity 2021 ·Redox Biology ·(unknown), Yanyan Yang, Shizhong Wang, Xiangqin He, Meixin Liu, Baochen Bai, Chao Tian, Ruicong Sun, Tao Yu, Xian‐Ming Chu	108
17	Left atrial myocardial function and compliance in pre-eclampsia with preserved left ventricular systolic and diastolic function 2020 ·International journal of cardiac imaging ·Fei Sun, Yong Li, (unknown), Lin Xu, Min Zhao, Rong Li, Xiangqin He, (unknown), Lei Ma, (unknown)	4
18	YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation 2020 ·Scientific Reports ·(unknown), Xiangqin He, Fang Liu, Shuping Yin, Shichao Wu, Maozhou Yang, Jiawei Zhao, Xiaohua Dai, Hong Jiang, (unknown), Qin Yin, Donghong Ju, (unknown), Leonard Lipovich, Youming Xie, Kezhong Zhang, (unknown), Jiliang Zhou, Li Li	10
19	Transcription factor TEAD1 is essential for vascular development by promoting vascular smooth muscle differentiation 2019 ·Cell Death and Differentiation ·Tong Wen, Jinhua Liu, Xiangqin He, Kunzhe Dong, Guoqing Hu, (unknown), Qin Yin, Islam Osman, Jingtian Peng, Zeqi Zheng, Hongbo Xin, David Fulton, Quansheng Du, Wei Zhang, Jiliang Zhou	38
20	Evaluation of Left Atrial Function in Physiological and Pathological Left Ventricular Myocardial Hypertrophy by Real‐time Tri‐plane Strain Rate Imaging 2009 ·Clinical Cardiology ·Pin Sun, Zhibin Wang, Jianxing Li, Jing Nie, Yan Li, Xiangqin He, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact